Patents by Inventor Syamal Roy

Syamal Roy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hemoglobin receptor as novel vaccine for leishmaniasis
    Patent number: 9764015
    Abstract: The present invention in general relates Hemoglobin receptor or its part as a novel vaccine candidate against Leishmaniasis. Specifically, the present invention envisages HbR DNA for eliciting immune response in a mammal against Leishmaniasis. Additional aspect of the present invention is related to a vaccine composition for inducing immune response against Leishmaniasis in mammals. In a preferred aspect, the present invention relates to use of HbR-polypeptide as marker for diagnosis of Leishmania in kala-azar patients.
    Type: Grant
    Filed: April 11, 2014
    Date of Patent: September 19, 2017
    Assignees: National Institute of Immunology, Indian Institute of Chemical Biology
    Inventors: Amitabha Mukhopadhyay, Syamal Roy, Deepika Gupta, Rajan Guha, Ruchir Rastogi
  • HEMOGLOBIN RECEPTOR AS NOVEL VACCINE FOR LEISHMANIASIS
    Publication number: 20150306195
    Abstract: The present invention in general relates Hemoglobin receptor or its part as a novel vaccine candidate against Leishmaniasis. Specifically, the present invention envisages HbR DNA for eliciting immune response in a mammal against Leishmaniasis. Additional aspect of the present invention is related to a vaccine composition for inducing immune response against Leishmaniasis in mammals. In a preferred aspect, the present invention relates to use of HbR-polypeptide as marker for diagnosis of Leishmania in kala-azar patients.
    Type: Application
    Filed: April 11, 2014
    Publication date: October 29, 2015
    Applicants: INDIAN INSTITUTE OF CHEMICAL BIOLOGY, NATIONAL INSTITUTE OF IMMUNOLOGY
    Inventors: Amitabha MUKHOPADHYAY, Syamal ROY, Deepika GUPTA, Rajan GUHA, Ruchir RASTOGI
  • DNA vaccine as immunoprophylaxis against Kala-azar
    Patent number: 8524677
    Abstract: A highly conserved membrane protein present in all species of Leishmania can be used as a vaccine antigen for genetic immunization against visceral leishmananiasis.
    Type: Grant
    Filed: March 13, 2007
    Date of Patent: September 3, 2013
    Assignee: Council of Scientific and Industrial Research
    Inventors: Rajatava Basu, Syamal Roy
  • DNA VACCINE AS IMMUNOPROPHYLAXIS AGAINST KALA-AZAR
    Publication number: 20080145385
    Abstract: A highly conserved membrane protein present in all species of Leishmania can be used as a vaccine antigen for genetic immunization against visceral leishmananiasis.
    Type: Application
    Filed: March 13, 2007
    Publication date: June 19, 2008
    Inventors: Rajatava Basu, Syamal Roy